Home Cart 0 Sign in  

[ CAS No. 645-49-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 645-49-8
Chemical Structure| 645-49-8
Structure of 645-49-8 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 645-49-8 ]

Related Doc. of [ 645-49-8 ]

Alternatived Products of [ 645-49-8 ]
Product Citations

Product Details of [ 645-49-8 ]

CAS No. :645-49-8 MDL No. :MFCD00004788
Formula : C14H12 Boiling Point : -
Linear Structure Formula :C2H2(C6H5)2 InChI Key :PJANXHGTPQOBST-QXMHVHEDSA-N
M.W : 180.25 Pubchem ID :5356785
Synonyms :

Calculated chemistry of [ 645-49-8 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 12
Fraction Csp3 : 0.0
Num. rotatable bonds : 2
Num. H-bond acceptors : 0.0
Num. H-bond donors : 0.0
Molar Refractivity : 61.81
TPSA : 0.0 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -3.98 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.72
Log Po/w (XLOGP3) : 4.81
Log Po/w (WLOGP) : 3.64
Log Po/w (MLOGP) : 5.24
Log Po/w (SILICOS-IT) : 4.1
Consensus Log Po/w : 4.1

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.49
Solubility : 0.00583 mg/ml ; 0.0000324 mol/l
Class : Moderately soluble
Log S (Ali) : -4.54
Solubility : 0.00517 mg/ml ; 0.0000287 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -5.0
Solubility : 0.00179 mg/ml ; 0.00000995 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 1.74

Safety of [ 645-49-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 645-49-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 645-49-8 ]

[ 645-49-8 ] Synthesis Path-Downstream   1~3

  • 1
  • [ 667458-78-8 ]
  • [ 645-49-8 ]
  • [ 103-30-0 ]
  • [ 349-58-6 ]
  • 2
  • [ 13667-12-4 ]
  • [ 645-49-8 ]
  • (Z)-1-(4-bromophenyl)-2-phenylethylene [ No CAS ]
YieldReaction ConditionsOperation in experiment
With n-butyllithium; 3-(4-hydroxybutyl)-1-mesityl-4,5-dihydro-1H-imidazol-3-ium hexafluorophosphate; hydrogen; copper(l) chloride; In tetrahydrofuran; at 60℃; under 37503.8 Torr; for 18h;Autoclave; General procedure: A 5 mL glass vial was charged with CuCl (0.02 mmol, 5 mol%) and ligand precursor 5c (0.03 mmol, 7.5 mol%). The vial was evacuated and refilled with N2 (3 ×). THF was added (1 mL for solid substrates; 1.5mL for liquid substrates), the mixture was stirred for 2 min at r.t. followed by the addition of n-BuLi (0.06 mmol, 15 mol%). The resulting mixture was stirred for 2 min at r.t. before the addition of the corresponding internal alkyne 10 (solid substrates were added as a solutionin 0.5 mL THF, liquid substrates were added neat). The rubber septum was punctured with a needle, the vial was placed in an autoclave and the mixture stirred (750 rpm) under H2 pressure (50 bar, unless otherwise noted). After completion of the reaction, all volatiles were removed under reduced pressure and the crude mixture was purified by column chromatography to give the desired product 11.
  • 3
  • [ 52092-47-4 ]
  • [ 645-49-8 ]
  • C19H15ClN2 [ No CAS ]
Recommend Products
Same Skeleton Products

Technical Information

Historical Records
; ;